<p>Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that primarily impacts the brain and spinal cord, affecting voluntary muscle control. Characterized by symptoms such as slurred speech, weakened grip, and increasing clumsiness, ALS leads to gradual loss of muscular function, ultimately making essential activities like walking, swallowing, and talking increasingly difficult. While the exact cause remains unknown, research suggests a combination of genetic factors, including mutations in the superoxide dismutase 1 (SOD1) gene in familial cases, and potential roles of increased glutamate levels and immune system involvement.</p> <p>Currently, there is no cure for ALS, and treatment focuses on providing symptomatic relief and supportive care, such as physical therapy and comfort measures. FDA-approved drugs like riluzole and edaravone may slow the progression of the disease but do not reverse the damage. As the condition advances, comprehensive care becomes essential, not just for managing physical challenges but also for addressing the psychological and emotional impacts on patients and their families. Research continues into potential biomarkers and treatments, including exploring links to viral causes, highlighting the need for ongoing scientific inquiry in ALS.</p>